|
Bill Hahn is an assistant professor of Medicine at Harvard Medical School. He is a medical oncologist and cancer researcher in the Department of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Hahn attended Harvard College and then Harvard Medical School where he completed his medical training and his graduate training in molecular and cellular immunology. After his residency in Internal Medicine at the Massachusetts General Hospital, Dr. Hahn completed a clinical fellowship in medical oncology at the Dana-Farber Cancer Institute and a postdoctoral fellowship with Dr. Robert A. Weinberg at the Whitehead Institute for Biomedical Research. He is currently on the faculties of the Harvard Medical School and the Dana-Farber Cancer Institute. His current work focuses on understanding the cooperative genetic interactions that lead to malignant transformation and the creation of novel experimental model systems for the study of normal and malignant epithelial biology. Clinically, he is a member of the Lank Center for Genitourinary Oncology and is devoted to the development of new therapeutic strategies for the treatment of prostate and lung cancers. | 